Canada: British Columbia Court Of Appeal De-Certifies Class Action—Was The Class Action Really Necessary?

On January 30, 2014, the British Columbia Court of Appeal de-certified a class action1 alleging violations of both the British Columbia Business Practices and Consumer Protection Act2 (the BPCPA) and the federal Competition Act.3 The court found that both pieces of legislation constitute complete codes, such that class members did not have the ability to bring tort or equitable claims alleging breaches of the legislation.

While certain aspects of the class members' claims remained after the tort and equitable claims were struck, the Court of Appeal went on to question the utility of the claims that remained and de-certified the class action, commenting that the sophisticated and scientifically supported regulatory system under the Food and Drugs Act4 (the FDA) had brought about the change in labeling sought. If the purpose of a class action is to redress "real injuries suffered by real people," the Court of Appeal noted it was worth asking whether anything might be meaningfully addressed in the context of the remaining aspects of the claim.

Of interest to litigants generally in class actions, the Court of Appeal was prepared to address the parties' legal questions head-on. The Court of Appeal confirmed it is beneficial to all concerned, including the justice system, if legal questions are directly addressed when raised at an early stage, rather than left for a trial that may never take place, or for another court in another case. It emphasized that scarce judicial resources may be squandered when difficult questions of law are continually sidestepped in the class action context as has been the case in the past.

Thus, while the cause of action test is often considered an easy one to meet in the context of class certification, it is not surmounted in all cases.

Background and facts

In 2008 Health Canada reversed a long-standing policy that had permitted the sale in Canada of certain children's non-prescription cough and cold medicines. Manufacturers had already voluntarily ceased marketing the medicines for use for children under age two, and as a result of the change in policy Health Canada required those manufacturers to re-label the medicines to instruct consumers that they should not be used for children under six.5

The plaintiff nonetheless filed an action and sought to certify a class action against the defendant manufacturers of the cough and cold medicines. She made no claims alleging that the cough medicines had injured any class members, but rather advanced claims for unjust enrichment, waiver of tort and constructive trust, on the basis of alleged statutory breaches under the BPCPA and Competition Act.6 The plaintiff also sought direct relief under the legislation. The motions judge granted certification on December 22, 2011,7 and the defendants subsequently launched an appeal.

The Court of Appeal's decision

The defendants argued, as a first ground of appeal, that the FDA's purposes would be frustrated if provisions regarding "deceptive practices" under the BPCPA were to apply to the packaging, labeling and sale of the medicines in question.8 The Court of Appeal shared the defendants' concerns regarding the possibility of different provincial laws applying across Canada to the labeling and marketing, and beneficial drugs being denied to some Canadians as a consequence.9 However, the Court of Appeal found that the FDA's purpose is primarily permissive and as such, the Court of Appeal was not convinced that applying the BPCPA to the marketing and sale of cold medicines would necessarily frustrate FDA purposes such that the BPCPA should be rendered inoperative.10

The Court of Appeal next turned to whether the statement of claim disclosed a cause of action.11 The defendants argued that, in addition to the damages that might be available to her individually under s. 171 of the BPCPA, the plaintiff had improperly sought to recover under restitutionary principles premised on this purported BPCPA breach.

The Court of Appeal found that consistent with its decision in Koubi v Mazda,12 released after the certification application was decided, the BPCPA is an "exhaustive code" for regulating consumer transactions and that so-called anti-enrichment claims premised on breach of the BPCPA were not available in law.13 The Court of Appeal concluded the reasoning in Koubi applied not only to the allegation of waiver of tort (which was specifically dealt with in Koubi), but also to the claims for unjust enrichment and constructive trust based upon the purported breach of the BPCPA.14

The defendants also argued that the claims for restitutionary remedies under the Competition Act advanced by the plaintiff were "judicially indistinguishable" from those advanced under the BPCPA in Koubi.15 The Court of Appeal agreed and determined nothing in the Competition Act indicated Parliament intended that the statutory right of action under the Competition Act should be augmented by a general right for consumers to sue in tort or to seek restitutionary remedies. As such, the pleadings did not disclose a cause of action as the Competition Act was a complete code.16

The Court of Appeal also accepted that there was no pleading that the plaintiff had sustained a loss or damage as a result of a breach of the Competition Act, and as such a direct claim under the Competition Act was not disclosed. Further, relying on recent Supreme Court of Canada authority, the Court of Appeal found that aggregate assessment provisions of the Class Proceedings Act, do not give rise to a cause of action for restitutionary remedies not already available under the BPCPA or the Competition Act.


In reversing the majority of the certification judge's finding, the Court of Appeal found that after the claims had been struck, the only claims that remained were for a declaration, injunctive relief, and an "advertising order" under the BPCPA. Given this, the Court of Appeal saw no alternative but to allow the appeal and decertify this proceeding, leaving the plaintiff at liberty to seek the certification of what remained of the action.17

The Court of Appeal noted that the case before it involved a "sophisticated and scientifically-supported regulatory system" in the form of the FDA regime, which in the Court of Appeal's words "exists for the express purpose of monitoring the marketing of pharmaceuticals in Canada." The Court of Appeal noted that this "system" has already brought about the changes sought by the plaintiff and if the purpose of class actions is to redress "real injuries suffered by real people" it was worth asking whether anything meaningful could be achieved by what remained of the lawsuit given the relief sought had been addressed by Health Canada and the defendants.

Of interest, the Court of Appeal in Quebec upheld the denial of authorization in a similar proposed class action (see our legal update), finding the allegations in that case did not demonstrate that the products were objectively harmful when used as directed, that the defendants had made false or misleading representations or had neglected to diligently disclose an important fact concerning the safety of their products.

Norton Rose Fulbright was counsel for certain of the defendants on the appeal.

The authors wish to thank law student Christopher Mamo for his help in preparing this legal update.


1 Wakelam v. Wyeth Consumer Healthcare/Wyeth Soins de Sante Inc. , 2014 BCCA 36 [Wakelam].

2 SBC 2004, c2.

3 RSC 1984, c C-34.

4 RSC 1985, c. F-27.

5 Wakelam, supra, at para 1.

6 Ibid, at para 4.

7 Ibid, at para 6.

8 Ibid, at para 16.

9 Ibid, at para 41.

10 Ibid, at para 42.

11 Ibid, at para 44.

12 2012 BCCA 310 [Koubi].

13 Wakelam, supra, at para 56.

14 Ibid, at para 66.

15 Ibid, at para 78.

16 Ibid, at para 90.

17 Ibid, at para 109.

Norton Rose Fulbright Canada LLP

Norton Rose Fulbright is a global legal practice. We provide the world's pre-eminent corporations and financial institutions with a full business law service. We have more than 3800 lawyers based in over 50 cities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia.

Recognized for our industry focus, we are strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare.

Wherever we are, we operate in accordance with our global business principles of quality, unity and integrity. We aim to provide the highest possible standard of legal service in each of our offices and to maintain that level of quality at every point of contact.

Norton Rose Fulbright LLP, Norton Rose Fulbright Australia, Norton Rose Fulbright Canada LLP, Norton Rose Fulbright South Africa (incorporated as Deneys Reitz Inc) and Fulbright & Jaworski LLP, each of which is a separate legal entity, are members ('the Norton Rose Fulbright members') of Norton Rose Fulbright Verein, a Swiss Verein. Norton Rose Fulbright Verein helps coordinate the activities of the Norton Rose Fulbright members but does not itself provide legal services to clients.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.